Tonix Pharmaceuticals Hol... (TNXP)

NASDAQ: TNXP · Real-Time Price · USD

19.95

1.91 (10.59%)

At close: May 02, 2025, 3:59 PM

19.84

-0.53%

After-hours: May 02, 2025, 05:54 PM EDT

Tonix Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-130.04M	-116.66M	-110.22M	-92.29M	-50.46M	-28.62M	-26.09M	-21.12M	-38.84M
Depreciation & Amortization	3.42M	4.29M	1.25M	50K	27K	26K	54K	70K	206K
Stock-Based Compensation	4.78M	9.28M	10.91M	7.9M	2.88M	1.46M	1.63M	1.79M	3.27M
Other Working Capital	7.04M	3.39M	1.04M	2.25M	-3.89M	-1.21M	331K	-289K	107K
Other Non-Cash Items	55.14M	1.12M	14.46M	3M	1.36M	-154K	1.63M	1.5M	133K
Deferred Income Tax	n/a	n/a	-14.46M	n/a	n/a	154K	n/a	n/a	n/a
Change in Working Capital	5.78M	-35K	-2K	5.78M	-2.37M	452K	437K	135K	-2.08M
Operating Cash Flow	-60.92M	-102M	-98.05M	-75.56M	-48.57M	-26.68M	-23.97M	-19.13M	-37.31M
Capital Expenditures	-120K	-7.89M	-48.15M	-35.31M	-8.56M	-17K	-6K	-5K	-66K
Cash Acquisitions	n/a	-22.17M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.17M	16.61M
Other Investing Acitivies	n/a	999K	n/a	n/a	n/a	-17K	-6K	7.17M	45K
Investing Cash Flow	-120K	-29.07M	-48.15M	-35.31M	-8.56M	-17K	-6K	7.17M	16.59M
Debt Repayment	-2.35M	8.94M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-13.96M	-47.25M	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	-6.66M	n/a	-451K	-2.47M	-3.27M	n/a	n/a
Other Financial Acitivies	-2.97M	41.54M	6.7M	98K	10.35M	2.58M	3.27M	14K	n/a
Financial Cash Flow	134.87M	36.52M	87.84M	212.49M	123.11M	12.92M	23.54M	18.52M	20.5M
Net Cash Flow	73.83M	-94.62M	-58.43M	101.59M	65.96M	-13.79M	-451K	6.55M	-234K
Free Cash Flow	-61.05M	-109.9M	-146.2M	-110.86M	-57.13M	-26.7M	-23.98M	-19.13M	-37.38M